MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities
- PMID: 28052821
- PMCID: PMC8311570
- DOI: 10.1016/bs.acr.2016.08.003
MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities
Abstract
Breast cancer is a worldwide health issue as it represents the leading cause of cancer in women and the second-leading cause of cancer-related mortality in women, with an increasing incidence. Nothing speaks more clearly to the shocking breast cancer health disparities than the fact that African American (AA) women are as likely to get breast cancer as Caucasian American (CA) women, yet have a higher breast cancer death rate. It is becoming increasingly apparent that racial disparity in cancer exists due to molecular differences in tumor biology as well as, or in addition to, socioeconomic and standard of care issues (Albain, Unger, Crowley, Coltman, & Hershman, 2009). A greater understanding of the risk factors and biological links associated with breast cancer, will significantly impact AA communities due to the higher deaths associated with this disease in this population. microRNAs are small noncoding RNA molecules that were recently discovered as major players in the regulation of many diseases including cancer. Although, there are many studies that have investigated the role of miRNAs in breast cancer, few have investigated their role if any in breast cancer disparities. This review serves to summarize the current published literature that is involved in the study of microRNAs and their impact on breast cancer disparities.
Keywords: Breast cancer; Cancer-associated fibroblast; Disparities; Single nucleotide polymorphisms; Tumor microenvironment; Tumor-associated macrophages; microRNA.
© 2017 Elsevier Inc. All rights reserved.
References
-
- Ahir M, Bhattacharya S, Karmakar S, Mukhopadhyay A, Mukherjee S, Ghosh S, … Adhikary A (2016). Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells. Biomaterials, 76, 115–132. 10.1016/j.biomaterials.2015.10.044.. S0142-9612(15)00854-6 [pii]. - DOI - PubMed
-
- Albain KS, Unger JM, Crowley JJ, Coltman CA Jr., & Hershman DL (2009). Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. Journal of the National Cancer Institute, 101(14), 984–992. 10.1093/jnci/djp175.. djp175 [pii]. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
